Axsome Therapeutics (AXSM) Amortization - Intangibles (2022 - 2026)

Axsome Therapeutics' Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Amortization - Intangibles changed 0.0% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $6.4 million (changed 0.0% YoY), while the FY2025 annual figure was $6.4 million, changed 0.27% from the prior year.
• Amortization - Intangibles came in at $1.6 million for Q1 2026 at Axsome Therapeutics, down from $1.6 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $1.6 million in Q3 2022 to a low of $926000.0 in Q2 2022.
• A 5-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Amortization - Intangibles.
• Across the five-year window, Amortization - Intangibles soared 71.6% in 2023 and fell 1.07% in 2025, its largest moves.
• Axsome Therapeutics' Amortization - Intangibles stood at $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then changed by 0.0% to $1.6 million in 2025, then retreated by 2.18% to $1.6 million in 2026.
• According to Business Quant data, Amortization - Intangibles over the past three periods registered $1.6 million, $1.6 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison